The effects, costs and benefits of Salmonella control in the Danish table-egg sector

Epidemiology and Infection

Volumn 137, Issue 6, 2009, Pages 828-836

  Korsgaard, H ^a   Madsen, M ^a   Feld, N C ^a   Mygind, J ^b   Hald, T ^a  

^a TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

^b DANISH VETERINARY AND FOOD ADMINISTRATION   (Denmark)

Author keywords

Cost benefit; Danish table egg sector; Human salmonellosis; Salmonella control programmes

Indexed keywords

ARTICLE; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DENMARK; DISEASE SURVEILLANCE; EGG PRODUCTION; FOOD CONTAMINATION; HEALTH CARE COST; HEALTH CARE PLANNING; HEALTH PROGRAM; HUMAN; INFECTION CONTROL; MAJOR CLINICAL STUDY; NONHUMAN; POULTRY; PROBABILITY; PUBLIC HEALTH; SALMONELLA; SALMONELLOSIS; ANIMAL; BIOLOGICAL MODEL; BIRD DISEASE; CHICKEN; ECONOMICS; EGG; METHODOLOGY; MICROBIOLOGY; STATISTICAL MODEL; TIME;

ANIMALS; CHICKENS; COMMUNICABLE DISEASE CONTROL; COST-BENEFIT ANALYSIS; DENMARK; EGGS; HUMANS; MODELS, BIOLOGICAL; MODELS, STATISTICAL; POULTRY DISEASES; PUBLIC HEALTH; SALMONELLA INFECTIONS; TIME FACTORS;

EID: 67649674635     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268808000903     Document Type: Article

References (16)

1. Anon. Annual report on zoonoses in Denmark 2005. Technical University of Denmark, the Ministry of Science, Technology and Innovation, Çopenhagen, Denmark, 2007.
2. Hald T, et al. The integrated surveillance of salmonella in Denmark and the effect on public health. In: Smulders JM, Collins JD, eds. Risk Management Strategies: Monitoring and Surveillance, 2004, pp. 213-238. (Food safety assurance and veterinary public health, vol. 3.)
3. Feld NC, et al. Evaluation of a serological salmonella mix-ELISA for poultry used in a national surveillance programme. Epidemiology and Infection 2000; 125: 263-268.
4. Skov MN, et al. The serologic response to Salmonella Enteritidis and Salmonella Typhimurium in experimentally infected chickens, followed by an indirect lipopolysaccharide enzyme-linked immunosorbent assay and bacteriologic examinations through a one-year period. Avian Disease 2002; 46: 265-273.
5. Wegener HC, et al. Salmonella control programs in Denmark. Emerging Infectious Diseases 2003; 9: 774-780.
6. Anon. The public salmonella control plan for table-egg and broiler production in Denmark [in Danish]. Ministry of Food, Agriculture and Fisheries, Copenhagen, Denmark, 2004.
7. Hald T, et al. A Bayesian approach to quantify the contribution of animal-food sources to human salmonellosis. Risk Analysis 2004; 24: 255-269.
8. Korsgaard H, Wegener HC, Helms M. The societal cost of zoonotic salmonella infections and other foodborne bacterial infections in Denmark [in Danish]. Ugeskrift for Laeger 2005; 67: 760-763.
9. Helms M, Simonsen J, Molbak K. Foodborne bacterial infection and hospitalization: A registry-based study. Clinical Infectious Diseases 2006; 42: 498-506.
10. Rosdahl N, Schmidt K. Diarrhoeal diseases requiring medical attention based on a population-based survey [in Danish]. Zoonosenyt 1996; 5: 6-7.
11. Molbak K, et al. An outbreak of multidrug-resistant, quinolone-resistant Salmonella enterica serotype Typhimurium DT104. New England Journal of Medicine 1999; 341: 1420-1425.
12. Statbank Denmark. Earnings for employees in the private sector (Table: LON03) and the central and local government (Table: LON33, LON43). Population estimates (Table: BEF1A) (http://www.statbank.dk). Accessed 1 February 2007.
13. Anon. Trends and sources of zoonotic agents in animals, feedingstuffs, food and man in the European Union and Norway in 2002. European Commission, Health and consumer protection directorate-general, 2004. SANCO/29/2004.
14. Patrick ME, et al. Salmonella Enteritidis infections, United States, 1985-1999. Emerging Infectious Diseases 2004: 10 1-7.
15. Voetsch AC, et al. FoodNet estimate of burden of illness caused by nontyphoidal Salmonella infections in the United States. Clinical Infectious Diseases 2004: 38: 127-134.
16. Weeler JG, et al. Study of infectious intestinal disease in England: Rates in community, presenting to general practice, and report to national surveillance. British Medical Journal 1999: 318: 1046-1050.